Your browser doesn't support javascript.
loading
Monitoring drug-target interactions through target engagement-mediated amplification on arrays and in situ.
Al-Amin, Rasel A; Johansson, Lars; Abdurakhmanov, Eldar; Landegren, Nils; Löf, Liza; Arngården, Linda; Blokzijl, Andries; Svensson, Richard; Hammond, Maria; Lönn, Peter; Haybaeck, Johannes; Kamali-Moghaddam, Masood; Jensen, Annika Jenmalm; Danielson, U Helena; Artursson, Per; Lundbäck, Thomas; Landegren, Ulf.
Afiliación
  • Al-Amin RA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Johansson L; Department of Medical Biochemistry and Biophysics, Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
  • Abdurakhmanov E; Department of Chemistry-BMC, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Landegren N; Center for Molecular Medicine, Department of Medicine (Solna), Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
  • Löf L; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Arngården L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Blokzijl A; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Svensson R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hammond M; Department of Pharmacy, Uppsala University Drug Optimization and Pharmaceutical Profiling (UDOPP), Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Lönn P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Haybaeck J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Kamali-Moghaddam M; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
  • Jensen AJ; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Danielson UH; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Artursson P; Department of Medical Biochemistry and Biophysics, Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
  • Lundbäck T; Department of Chemistry-BMC, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Landegren U; Department of Pharmacy, Uppsala University Drug Optimization and Pharmaceutical Profiling (UDOPP), Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Nucleic Acids Res ; 50(22): e129, 2022 12 09.
Article en En | MEDLINE | ID: mdl-36189884
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida Idioma: En Revista: Nucleic Acids Res Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida Idioma: En Revista: Nucleic Acids Res Año: 2022 Tipo del documento: Article País de afiliación: Suecia